Your browser doesn't support javascript.
loading
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Goldberg, Sarah B; Schalper, Kurt A; Gettinger, Scott N; Mahajan, Amit; Herbst, Roy S; Chiang, Anne C; Lilenbaum, Rogerio; Wilson, Frederick H; Omay, Sacit Bulent; Yu, James B; Jilaveanu, Lucia; Tran, Thuy; Pavlik, Kira; Rowen, Elin; Gerrish, Heather; Komlo, Annette; Gupta, Richa; Wyatt, Hailey; Ribeiro, Matthew; Kluger, Yuval; Zhou, Geyu; Wei, Wei; Chiang, Veronica L; Kluger, Harriet M.
Afiliación
  • Goldberg SB; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA. Electronic address: sarah.goldberg@yale.edu.
  • Schalper KA; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Gettinger SN; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Mahajan A; Department of Radiology, Yale School of Medicine, New Haven, CT, USA.
  • Herbst RS; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Chiang AC; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Lilenbaum R; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Wilson FH; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Omay SB; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
  • Yu JB; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
  • Jilaveanu L; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Tran T; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Pavlik K; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Rowen E; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Gerrish H; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Komlo A; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Gupta R; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Wyatt H; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Ribeiro M; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
  • Kluger Y; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Zhou G; Interdepartmental Program in Computational Biology and Bioinformatics, Yale School of Medicine, New Haven, CT, USA.
  • Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
  • Chiang VL; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
  • Kluger HM; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.
Lancet Oncol ; 21(5): 655-663, 2020 05.
Article en En | MEDLINE | ID: mdl-32251621
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article